Addressing a significant issue in neonatal healthcare while helping to also address Joint Commission Sentinel Event alerts, B. Braun Medical Inc. (B. Braun) announced today its alliance with NeoMed, Inc. a manufacturer of medical devices specifically designed to enhance patient safety and clinical outcomes of the neonatal patient. The partnership, consisting of B. Brauns Perfusor® SPACE Syringe Pump and NeoMed®s Enteral Safety System, will help healthcare professionals prevent enteral/IV misconnections and medication errors.
Â
Catheter/tubing misconnections continue to contribute to serious, life threatening errors when clinicians mistakenly administer oral/enteral liquids through IV lines rather than through an enteral feeding tube, says Gale White, vice president of infusion systems marketing for B. Braun Medical Inc. The combination of both B. Brauns Perfusor SPACE Syringe Pump and NeoMeds Enteral Safety System promises the opportunity to provide healthcare professionals with a unique connector that allows for the safest, most accurate delivery of both enteral feedings and enteral medications. Perfusor SPACE Syringe Pump is the only syringe pump that recognizes 3 through 60cc NeoMed enteral syringes guaranteeing accuracy of flow at +/-2% using NeoMed syringes and extension sets.
Â
Designed with both adult and pediatric healthcare facilities in mind, the small, lightweight SPACE Infusion System allows for flexibility and easy transport within a number of care settings. At 9 inches by 6 inches and weighing only three pounds, it has the capability to stack up to 16 pumps in any combination of syringe and large volume within a single bedside tower allowing the SPACE system to meet the needs of any clinical setting. The SPACE system offers the latest in dose error reduction software with a large customizable drug library well suited to pediatric environments.
Â
The collaboration between B. Braun and NeoMed will help to address an unfortunately and increasingly common patient safety crisis in healthcare today, says Tony Lair, president and CEO of NeoMed. Working together we can ensure clinicians have the tools they need to make certain catheter/tubing misconnections are an issue of the past ultimately helping to prevent serious harm or death.Â
Â
NeoMeds Enteral Safety System includes oral dispensers, enteral only extension sets and feeding tubes that are designed to be incompatible with IV or Luer Locking devices. The offset tip allows for delivery of Colostrum into the patient first and has a trademarked orange silk screen which identifies with an orange extension set and orange feeding tube, allowing for visual color coordination complying with Joint Commission, FDA and ASPEN recommendations.Â
Â
For more information, visit www.space.bbraunusa.com.
Â
Â
Â
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.